Rusan Pharma invests Rs. 300 crore in API plant: MP

The commitment to progress is evident as Rusan Pharma plans a comprehensive investment exceeding Rs 300 crore for the development of its API facility in two distinct phases.

107
medicine Drugs Tablets Pills
Picture: Pixabay

Rusan Pharma

In a significant stride towards innovation and excellence, Rusan Pharma has unveiled its cutting-edge Active Pharmaceutical Ingredient (API) facility in Pithampur, Special Economic Zone (SEZ), Madhya Pradesh.

This facility, representing a total investment of up to Rs 300 crore over two phases, marks a crucial step in meeting the increasing demand for addiction treatment and pain management products, both in India and on a global scale.

Investment of Rusan Pharma

The commitment to progress is evident as Rusan Pharma plans a comprehensive investment exceeding Rs 300 crore for the development of its API facility in two distinct phases.

This strategic approach underscores the company’s dedication to scaling up its operations and ensuring a secure supply of critical APIs.

Ensuring Regulatory Compliance

The facility’s design is meticulously crafted to adhere to stringent international regulatory guidelines.

This commitment to compliance positions Rusan Pharma at the forefront of quality assurance, fostering confidence among stakeholders and end-users.

Impressive Production Capability

With a robust production capability of 400 metric tones of APIs annually, Rusan Pharma’s new facility is poised to make a substantial impact on the pharmaceutical landscape.

This increased capacity aligns with the growing demand for the company’s addiction treatment and pain management products.

Rusan Pharma’s Vision

Dr. Navin Saxena, Founder and Chairman of Rusan Pharma, expresses his optimism about the new API facility.

He states, “The new API facility in Pithampur will enable Rusan to significantly enhance our existing API capacity and ensure the security of supply of critical APIs to meet the growing demand for our addiction treatment and pain management products in India and globally.”

Strategic Location and Government Support

Situated strategically within the Pithampur SEZ, the facility benefits from the support and subsidies provided by the Madhya Pradesh state government.

This central location streamlines business operations and export processes through the dry port, ensuring efficiency and cost-effectiveness.

The facility’s location in a dedicated pharmaceutical zone adds an extra layer of assurance by providing a cleaner environment, minimizing the risk of pollution from other industries in the area.

Advanced Infrastructure and Control

Dr. Kunal Saxena, Managing Director of Rusan Pharma, sheds light on the advanced features of the new plant.

Boasting five modular API manufacturing blocks with dedicated suites for finished API manufacturing, the facility grants complete control over product quality.

This approach reduces dependency on imports, aligning seamlessly with Rusan Pharma’s commitment to excellence.

Technological Advancements and Environmental Considerations

Incorporating advanced automation and compliant software, Rusan Pharma is moving towards paperless manufacturing.

Additionally, stringent environmental controls are in place, reflecting the company’s dedication to responsible and sustainable pharmaceutical production.

Affordability and Accessibility

Dr. Kunal Saxena further emphasizes, “Incorporating advanced automation and compliant software will help us move towards paperless manufacturing, along with stringent environmental controls, which will enable us to produce essential medicines more affordably, expanding accessibility to a broader population.”

Conclusion

In conclusion, Rusan Pharma’s state-of-the-art API facility in Pithampur is a beacon of progress in the pharmaceutical industry.

The company’s commitment to quality, compliance, and innovation positions it as a key player in meeting the healthcare demands of today and tomorrow.

FAQs

  1. What is the total investment in Rusan Pharma’s new API facility?
    • The total investment in the facility is expected to be up to Rs 300 crore over two phases.
  2. What is the production capability of the new API facility?
    • The facility has a robust production capability of 400 metric tonnes of APIs annually.
  3. How does the facility ensure regulatory compliance?
    • The facility is designed meticulously to meet stringent international regulatory guidelines.
  4. What is the significance of the facility’s strategic location within the Pithampur SEZ?
    • The strategic location streamlines business operations, export processes, and benefits from government support and subsidies.
  5. How does Rusan Pharma contribute to environmental sustainability?
    • The facility incorporates advanced automation, compliant software, and stringent environmental controls for responsible pharmaceutical production.

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news